ARTICLE | Clinical News
Autologous T cell therapy against CD19: Clinical trial data
January 25, 2016 8:00 AM UTC
Data from 41 evaluable patients with hematologic malignancies in clinical trials at NIH’s NCI showed that KTE-C19 led to an ORR of 78%, including 22 complete responses. In 27 patients with aggressive ...